DISCOVERY LIFE PAYS R10.5 BILLION TO CLIENTS IN 2023

Loading player...
GUEST – Kashmeera Kanji - Discovery Life Head of Market Analytics, Research & Development

Discovery Life published its 2023 claims experience showing positive trends in earlier detection of severe illnesses, influenced by an increase in health screenings, and significant decrease in COVID-19 claims. In 2023, Discovery Life paid claims to the value of R8.4 billion across both Group Risk and Individual Life policies. The company paid R6.45 billion in claims for individual life policies.

This consisted of 8,912 unique claims, which includes R3 billion in death claims. R1.5 billion was paid through the Severe Illness Benefit, R1 billion under the Capital Disability Benefit, R613 million under the Income Continuation Benefit, and R298 million under various other benefits. This brings the total value of claims paid under individual life policies to over R53 billion to date. Discovery Life also paid out R2.1 billion in Shared-value benefits, rewarding clients for managing their health and finances well, bringing the total paid to clients in the year to over R10 billion.
22 Apr 2024 2PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min